Cargando…

Multimodal imaging-based diagnostic approach for MRI-negative posterior cortex epilepsy

BACKGROUND: Posterior cortex epilepsy (PCE) primarily comprises seizures originating from the occipital, parietal, and/or posterior edge of the temporal lobe. Electroclinical dissociation and subtle imaging representation render the diagnosis of PCE challenging. Improved methods for accurately ident...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, Jiajie, Dong, Wenyu, Sang, Lin, Zheng, Zhong, Guo, Qiang, Zhou, Xiuming, Zhou, Wenjing, Wang, Haixiang, Meng, Xianghong, Yao, Yi, Wang, Fengpeng, Hu, Wenhan, Zhang, Kai, Shao, Xiaoqiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Therapeutic Advances in Refractory Epilepsy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657531/ https://www.ncbi.nlm.nih.gov/pubmed/38021475 http://dx.doi.org/10.1177/17562864231212254

Ejemplares similares

Multimodal prognostic features of seizure freedom in epilepsy surgery
por: Alim-Marvasti, Ali, et al.
Publicado: (2022)

Temporal lobe epilepsy and affective disorders: the role of the subgenual anterior cingulate cortex
por: Stretton, J, et al.
Publicado: (2015)

Advances in epilepsy surgery
por: Nowell, Mark, et al.
Publicado: (2014)

NMDA receptor binding in focal epilepsies
por: McGinnity, C J, et al.
Publicado: (2015)

Meyer's loop asymmetry and language lateralisation in epilepsy
por: Nowell, Mark, et al.
Publicado: (2016)

Cannabidiol and epilepsy in Brazil: a current review
por: Oshiro, Carlos André, et al.
Publicado: (2022)

Latency of poststroke epilepsy can predict drug resistance
por: Lattanzi, Simona, et al.
Publicado: (2022)

Time to 12-month remission and treatment failure for generalised and unclassified epilepsy
por: Bonnett, Laura J, et al.
Publicado: (2014)

Increased prevalence of ECG markers for sudden cardiac arrest in refractory epilepsy
por: Lamberts, R J, et al.
Publicado: (2015)

Retinal nerve fibre layer thinning is associated with drug resistance in epilepsy
por: Balestrini, Simona, et al.
Publicado: (2016)

Real-life survey of pitfalls and successes of precision medicine in genetic epilepsies
por: Balestrini, Simona, et al.
Publicado: (2021)

Post-traumatic epilepsy in adults: a nationwide register-based study
por: Karlander, Markus, et al.
Publicado: (2021)

Adult-onset epilepsy and risk of traumatic brain injury: a nationwide cohort study
por: Posti, Jussi P, et al.
Publicado: (2023)

Epilepsy and Malaria in Children Aged 1 to 15 Years in Parakou in 2018: Case-Control Study
por: Thierry, Adoukonou, et al.
Publicado: (2020)

Responsive neurostimulation of the thalamus improves seizure control in idiopathic generalised epilepsy: initial case series
por: Sisterson, Nathaniel D, et al.
Publicado: (2022)

Adult onset epilepsy incidence in Finland over 34 years: A nationwide registry study
por: Sipilä, Jussi O. T., et al.
Publicado: (2021)

Stratifying sudden death risk in adults with drug‐resistant focal epilepsy: The SUDEP‐CARE score
por: Serrand, Chris, et al.
Publicado: (2022)

Complications to invasive epilepsy surgery workup with subdural and depth electrodes: a prospective population-based observational study
por: Hedegärd, Emelie, et al.
Publicado: (2014)

Cognitive-behavioural therapy does not meaningfully reduce depression in most people with epilepsy: a systematic review of clinically reliable improvement
por: Noble, Adam J, et al.
Publicado: (2018)

Stopping Antiepileptic Drugs: When and Why?
por: Hixson, John D.
Publicado: (2010)

Cardiac arrhythmias during or after epileptic seizures
por: van der Lende, Marije, et al.
Publicado: (2016)

Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health
por: Mostacci, Barbara, et al.
Publicado: (2018)

Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial
por: Vossler, David G, et al.
Publicado: (2020)

Status epilepticus: review on diagnosis, monitoring and treatment
por: Pinto, Lecio Figueira, et al.
Publicado: (2022)

Valproate in status epilepticus: Correlation between loading dose, serum levels, and clinical response
por: Vijiala, Sergiu, et al.
Publicado: (2022)

Out‐of‐hospital versus in‐hospital status epilepticus: The role of etiology and comorbidities
por: Brigo, Francesco, et al.
Publicado: (2022)

Care in Europe after presenting to the emergency department with a seizure; position paper and insights from the European Audit of Seizure Management in Hospitals
por: Taylor, Claire, et al.
Publicado: (2022)

Increased delta power as a scalp marker of epileptic activity: a simultaneous scalp and intracranial electroencephalography study
por: De Stefano, Pia, et al.
Publicado: (2021)

Longitudinal analysis of the relationship between motor and psychiatric symptoms in idiopathic dystonia
por: Bailey, Grace A., et al.
Publicado: (2022)

Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial
por: Nakamura, Kensuke, et al.
Publicado: (2023)

P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin’s lymphoma.
por: Mangasarova, Ya.K., et al.
Publicado: (2022)

P103: Comparison of PET-derived parameters in program cell death-1 inhibitor and CD30 antibody drug conjugate-based therapies in patients with advanced stage cHL: A single center experience.
por: Kamel, Serageldin, et al.
Publicado: (2022)

P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma
por: Shah, Harsh, et al.
Publicado: (2022)

P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.
por: Michalka, Jozef, et al.
Publicado: (2022)

P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
por: Calabretta, Eleonora, et al.
Publicado: (2022)

P106: Dose intensive brentuximab vedotin for platinum resistant recurrent Hodgkin lymphoma is a feasible treatment option - a single center experience
por: Erenmalm, Axel, et al.
Publicado: (2022)

P109: One-Day Brentuximab-Bendamustine (120mg/m2) every 21 days is a feasible and safe treatment for relapsed/refractory Hodgkin lymphoma
por: Moatti, Hannah, et al.
Publicado: (2022)

T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory Hodgkin lymphoma
por: Moskowitz, Alison J., et al.
Publicado: (2022)

P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2022)

T100: Long term Follow-up of a Phase I Study Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A trial of the ECOG-ACRIN Research Group (E4412: Arms A-I)
por: Diefenbach, Catherine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3hcfksm9bdcnmr2rt7c190a7kp